Bausch Health Cos Profit Margin 2006-2018 | BHC

Current and historical gross margin, operating margin and net profit margin for Bausch Health Cos (BHC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Bausch Health Cos net profit margin as of December 31, 2018 is -50.83%.
Bausch Health Cos Annual Profit Margins
Bausch Health Cos Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $8.210B $8.380B
Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is based in NJ, United States.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $47.288B 8.51
Teva Pharmaceutical Industries (TEVA) Israel $15.162B 5.23
Mylan (MYL) United Kingdom $13.724B 5.81
Dr Reddy's Laboratories (RDY) India $6.790B 27.08
Supernus Pharmaceuticals (SUPN) United States $1.951B 18.10
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.534B 2.49
Amphastar Pharmaceuticals (AMPH) United States $0.979B 90.43
Homology Medicines (FIXX) United States $0.873B 0.00
CymaBay Therapeutics (CBAY) United States $0.742B 0.00
Voyager Therapeutics (VYGR) United States $0.677B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.429B 0.00
Assembly Biosciences (ASMB) United States $0.389B 0.00
Akorn (AKRX) United States $0.374B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.209B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.175B 0.00
Sol-Gel Technologies (SLGL) Israel $0.133B 0.00
Acasti Pharma (ACST) Canada $0.069B 0.00
Agile Therapeutics (AGRX) United States $0.063B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.063B 0.00
Teligent (TLGT) United States $0.053B 0.00
China Pharma Holdings (CPHI) China $0.015B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Evoke Pharma (EVOK) United States $0.012B 0.00